<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?>
<rss version="2.0">
  <channel>
    <title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
    <link>http://www.prweb.com</link>
    <description>PRWeb.com Press Release Feed - Press Releases</description>
    <language>en</language>
    <image>
      <title>PRWeb Distribution Newswire</title>
      <url>http://www.prweb.com/images_v4/prweb_logo_hv.jpg</url>
      <link>http://www.prweb.com</link>
      <width>200</width>
      <height>46</height>
    </image>
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>
    <ttl>30</ttl>

<item>
    <title>Lorenzen Cancer Foundation Urges Cancer Drug Coverage in the Prescription Drug Benefit Act</title>
    <link>http://www.prweb.com/releases/2004/07/prweb139448.htm</link>
    <description>
        <![CDATA[  <P>In the interests of cancer patients and oncologists nationwide, the Lorenzen Cancer Foundation (LCF), a non-profit dedicated to fighting pancreatic cancer, has joined the public interest law firm Washington Legal Foundation (WLF) and others today in presenting a written comments statement to the U.S. Centers for Medicare and Medicaid Services (CMS) voicing support for the Section 641 demonstration project and expressing concerns regarding CMS&#8217;s proposed restrictions limiting coverage of the drug benefit to exclude off-label uses of FDA-approved drug or biological therapies.   (PRWeb Jul 7, 2004)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2004/07/prweb139448.htm">http://www.prweb.com/releases/2004/07/prweb139448.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2004/07/prweb139448.htm</guid>
</item>

<item>
    <title>Foundation Urges Medicare Officials to Cover Cancer Drugs</title>
    <link>http://www.prweb.com/releases/2004/02/prweb104780.htm</link>
    <description>
        <![CDATA[  <P>In the interests of cancer patients and oncologists nationwide, the Lorenzen Cancer Foundation (LCF) has joined the public interest law firm Washington Legal Foundation (WLF) and others today in presenting a written comments statement to the U.S. Centers for Medicare and Medicaid Services (CMS) requesting an end to the prolonged coverage review of several important cancer treatments.  The statement urged CMS officials to reinstate a clear reimbursement policy for off-label use of these drugs. (PRWeb Feb 14, 2004)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2004/02/prweb104780.htm">http://www.prweb.com/releases/2004/02/prweb104780.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2004/02/prweb104780.htm</guid>
</item>

</channel>
</rss>